Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- INV-9956Phase 21 trial
Shenzhen Ionova Life Sciences Co., Ltd. · Advanced Metastatic Castration Resistant Prostate Cancer
- Invobenitug also known as ProcizumabAK1967Phase 21 trial
4TEEN4 Pharmaceuticals GmbH · Shock, Cardiogenic
- INX-315Phase 21 trial
Incyclix Bio · Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor
- IO-108Phase 21 trial
Roche (Genentech) · Advanced Liver Cancers
- ION337Phase 21 trial
Ionis Pharmaceuticals · Dravet Syndrome
- ION440Phase 21 trial
Ionis Pharmaceuticals · Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
- ION717Phase 21 trial
Ionis Pharmaceuticals · Prion Disease
- ION775Phase 21 trial
Ionis Pharmaceuticals · Hypertriglyceridemia, Severe Hypertriglyceridemia
- IOV-3001Phase 21 trial
Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Ocular Melanoma
- IOV-4001Phase 21 trial
Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Stage III Non-small Cell Lung Cancer
- IOV-5001Phase 21 trial
Iovance Biotherapeutics, Inc. · Advanced Solid Tumors, Non-Small Cell Lung Cancer, Triple Negative Breast Cancer (TNBC)
- IPG1094Phase 21 trial
Nanjing Immunophage Biotech Co., Ltd · Solid Tumor
- IPH5201Phase 21 trial
Innate Pharma · Non Small Cell Lung Cancer
- IPN01194Phase 21 trial
Ipsen · Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma
- IPN01195Phase 21 trial
Ipsen · Advanced Solid Tumor
- IPN01203Phase 21 trial
Ipsen · Advanced Solid Tumor, Metastatic Solid Tumor
- IPN60300Phase 21 trial
Ipsen · Locally Advanced Solid Tumor, Metastatic Solid Tumor
- IPN60350Phase 21 trial
Ipsen · Neoplasms, Neoplasm Metastasis, Neoplastic Processes
- IRL757Phase 21 trial
Integrative Research Laboratories AB · PARKINSON DISEASE (Disorder), Apathy, Safety
- iscalimabCFZ533Phase 21 trial
Novartis · Hidradenitis Suppurativa
- ISLA101fenretinidePhase 21 trial
Island Pharmaceuticals · Dengue
- ISM3412Phase 21 trial
InSilico Medicine Hong Kong Limited · Locally Advanced/Metastatic Solid Tumors
- ISM6331Phase 21 trial
InSilico Medicine Hong Kong Limited · Malignant Mesothelioma, Metastatic Malignant Solid Tumor, Advanced Solid Tumor
- ITU512Phase 21 trial
Novartis · Sickle Cell Disease
- IvaltinostatPhase 21 trial
CG Pharmaceuticals, Inc · Metastatic Pancreatic Adenocarcinoma
- IVIEW-1201Phase 21 trial
IVIEW Therapeutics Inc. · Fungal Keratitis
- IVL3003Phase 21 trial
Inventage Lab., Inc. · Alzheimer Disease
- IVMED-85Phase 21 trial
iVeena Delivery Systems, Inc. · Myopia, Progressive
- IW-6463CY6463, zagociguatPhase 21 trial
Tisento Therapeutics · Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
- JAB-2485Aurora A inhibitorPhase 21 trial
Jacobio Pharmaceuticals Co., Ltd. · Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC
- JAB-30355Phase 21 trial
Jacobio Pharmaceuticals Co., Ltd. · Solid Tumors
- JB100Phase 21 trial
EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma
- JBI-778Phase 21 trial
Jubilant Therapeutics Inc. · Brain Metastases From Solid Tumors, Leptomeningeal Disease, High Grade Glioma (HGG)
- JBI-802Phase 21 trial
Jubilant Therapeutics Inc. · Essential Thrombocythemia (ET), Polycythemia Vera
- JCXH-105Phase 21 trial
Immorna Biotherapeutics, Inc. · Herpes Zoster (HZ), Infectious Diseases, Shingles
- JDB0131Phase 21 trial
WestVac Biopharma Co., Ltd. · Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
- JK06Phase 21 trial
Salubris Biotherapeutics Inc · Solid Tumor
- JK07Phase 21 trial
Salubris Biotherapeutics Inc · Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction
- JKN2304Phase 21 trial
Joincare Pharmaceutical Group Industry Co., Ltd · COPD (Chronic Obstructive Pulmonary Disease), COPD
- JKN24011Phase 21 trial
Joincare Pharmaceutical Group Industry Co., Ltd · COPD (Chronic Obstructive Pulmonary Disease)
- JKN2403Phase 21 trial
Joincare Pharmaceutical Group Industry Co., Ltd · COPD (Chronic Obstructive Pulmonary Disease)
- JL15003InjectionPhase 21 trial
Jecho Biopharmaceuticals Co., Ltd. · Recurrent Glioblastoma Multiforme(GBM)
- JL18008Phase 21 trial
Jecho Biopharmaceuticals Co., Ltd. · HIV Infections
- JMBI-001Phase 21 trial
Chengdu Anticancer Bioscience, Ltd. · Advance Solid Tumors, Lymphoma, Non-Hodgkin
- JMKX000197Phase 21 trial
Shanghai Jeyou Pharmaceutical Co., Ltd. · Malignant Pleural Effusions (Mpe)
- JMT202Phase 21 trial
Shanghai JMT-Bio Inc. · Hypertriglyceridemia
- JMT203Phase 21 trial
Shanghai JMT-Bio Inc. · Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia
- JMT601Phase 21 trial
Shanghai JMT-Bio Inc. · Primary Membranous Nephropathy
- JNJ-64042056Phase 21 trial
Johnson & Johnson (Janssen) · Alzheimer Disease
- JNJ-88545223Phase 21 trial
Johnson & Johnson (Janssen) · Arthritis, Psoriatic
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.